Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
Clinical trial NCT00626990 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00626990
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2018-09-05
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.